Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats

Medical Science Monitor

Volumn 11, Issue 4, 2005, Pages

  Hosseinzadeh, Hossein ^a   Parvardeh, Siavash ^a   Nassiri Asl, Marjan ^a   Mansouri, Mohammad Taghi ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticonvulsant; BZD receptor; Nigella sativa; Opioid receptors; Pentylenetetrazole; Thymoquinone

Indexed keywords

DIAZEPAM; FLUMAZENIL; KETAMINE; NALOXONE; NIGELLA SATIVA EXTRACT; OPIATE RECEPTOR; PENTETRAZOLE; THYMOQUINONE; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BLACK CUMIN; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; GABAERGIC SYSTEM; HYPNOSIS; LOCOMOTION; MALE; MOTOR COORDINATION; MUSCLE RELAXATION; NEUROPHARMACOLOGY; NONHUMAN; RAT; SEIZURE; TONIC CLONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; BENZOQUINONES; CONVULSANTS; DIAZEPAM; EPILEPSY; FLUMAZENIL; INJECTIONS, INTRAVENTRICULAR; MALE; NIGELLA; PENTYLENETETRAZOLE; PHYTOTHERAPY; RATS; RATS, WISTAR; SEEDS; SEIZURES;

EID: 17444422880     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Jansen PCM: Spices, Condiments and Medicinal Plants in Ethiopia, their Taxonomy and Agricultural Significance. Addis Ababa: Center for Agricultural Publishing and Documentation, 1981; 76-85
2. Siddiqui AA, Sharma PKR: Clinical importance of Nigella sativa L. a review. Hamdard Medicus, 1996; 39: 38-42
3. Worthen DR, Ghoshe, OA, Crooks PA: The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Res, 1998; 18: 1527-32
4. Mahfouz M, Abdel-Meguid R, El-Dakhakimy M: Effectiveness of 'Nigella' in Asthma. Alexandria Medical Journal, 1960; 6: 543-47
5. Filippo D'Antuono L, Moretti A, Lovato Antonio FS: Seed yield, yield components, oil content and essential oil content and composition of Nigella sativa L. and Nigella damascene L. Indust Crops Prod, 2002; 15: 59-69
6. Abdel-Fattah AFM, Matsumoto K, Watanabe H: Antinociceptive effects of Nigeflla sativa oil and its major component, thymoquinone, in mice. Eur J Pharmacol, 2000; 400: 89-97
7. Houghton PI, Zarka R, De las Heras B, Hoult RS: Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med, 1995; 61: 33-36
8. Hassan M, El-Dakhakhny M: Effect of some Nigella sativa constituents on chemical cardnogenesis in hamster cheek pouch. J Egypt Soci Pharmacol Exp Ther, 1992; 11: 675-77
9. Khanna T, Zaidi FA, Dandiya PC: CNS and analgesic studies on Nigella sativa. Fitoterapia, 1993; 64: 407-10
10. Hosseinzadeh H, Parvardeh S: Anticonvulsant effect of thymoquinone, the major constituent of Nigella sativa seeds, in mice. Phytomedicine, 2004; 11: 56-64
11. Paxions G, Watson C: The Rat Brain in Stereotaxic Coordinates, New York: Academic Press, 1998
12. Hosseinzadeh H, Khosravan V: Anticonvulsant effects of aqueous and ethanolic extracts of Crocus salivus L. stigmas in mice. Arch Irn Med, 2002; 5: 45-48
13. Hosseinzadeh H, Madanifard M: Anticonvulsant effects of Coriandrum salivum L. seeds extracts in mice. Arch Irn Med, 2000; 3: 182-84
14. File SE, Pellow S: Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacoogyl, 1986; 88: 1-11
15. Macdonald RL, Barker JL: Pentylenetetrazole and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurons. Nature, 1977; 267: 720-22
16. 3H]-diazepam binding. In vitro, correlation with convulsant potency. Eur J Pharmacol, 1982; 78: 353-56
17. Brogden RN, Goa KL: Flumazenil: a preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use. Drugs, 1988; 35: 448-67
18. Yajima Y, Naritaa M, Takahashi-Nakano Y et al: Effects of differential modulation of μ-, δ- and κ-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res, 2000; 862: 120-26
19. Werz RL, Macdonald MA: Dynorphin reduces voltage-dependent calcium conductance of mouse dorsal root ganglion neurons. Neuropept, 1984; 5: 253-56
20. Werz MA, Macdonald RL: Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration. J Pharmacol Exp Ther, 1985; 234: 49-56